Journal of Genetic Counseling

, Volume 21, Issue 2, pp 305–325 | Cite as

Barriers to and Motivations for Physician Referral of Patients to Cancer Genetics Clinics

  • Carrie F. Prochniak
  • Lisa J. Martin
  • Erin M. Miller
  • Sara C. Knapke
Original Research

Abstract

Although it is well known that under-referral of colon cancer patients to cancer genetics clinics is a chronic problem, no study has yet examined why physicians may be ordering testing independently rather than referring patients to cancer genetics clinics. The current study explored variables which may impact a physician’s preference for ordering testing independently or referring patients to outside cancer genetics experts. An online questionnaire, distributed to the membership of the American College of Gastroenterology and the American Society of Colorectal Surgeons, yielded responses from 298 physicians. Motivations to refer to cancer genetics clinics rather than order testing independently included fear of genetic discrimination and a belief that patients benefit from genetic counseling about the risks, benefits and consequences of testing. These results suggest that in order to increase referrals, genetic counselors must educate physicians about the unique benefits patients receive from participating in genetic counseling.

Keywords

Genetic counseling Hereditary colorectal cancer Genetic testing Referral Risk assessment 

References

  1. American Cancer Society. (2008). Colorectal cancer facts & figures 2008–2010. Atlanta: American Cancer Society.Google Scholar
  2. American Cancer Society Colorectal Cancer Advisory Group, U.S. Multi-society Task Force, & American College of Radiology Colon Cancer Committee. (2008). Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA: A Cancer Journal for Clinicians, 58, 130–160.CrossRefGoogle Scholar
  3. American Gastroenterological Association. (2001). American Gastroenterological Association medical position statement: Hereditary colorectal cancer and genetic testing. Gastroenterology, 121, 195–197.CrossRefGoogle Scholar
  4. American Society for Gastrointestinal Endoscopy. (2006). ASGE guideline: Colorectal cancer screening and surveillance. Gastrointestinal Endoscopy, 63(4), 546–557.CrossRefGoogle Scholar
  5. American Society of Clinical Oncology. (2005). Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology guideline. Journal of Clinical Oncology, 23(33), 8512–8519.CrossRefGoogle Scholar
  6. Batra, S., Valdimarsdottir, H., McGovern, M., Itzkowitz, S., & Brown, K. (2002). Awareness of genetic testing for cancer predisposition among specialists in gastroenterology. American Journal of Gastroenterology, 97(3), 729–733.PubMedCrossRefGoogle Scholar
  7. Bellcross, C., Kotor, K., Goddard, K. A. B., Coates, R. J., Reyes, M., & Khoury, M. J. (2011). Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians. American Journal of Preventive Medicine, 40(1), 61–66.PubMedCrossRefGoogle Scholar
  8. Bleiker, E. M. A., Hahn, D. E. E., & Aaronson, N. K. (2003). Psychosocial issues in cancer genetics: Current status and future directions. Acta Oncologica, 42(4), 276–286.PubMedCrossRefGoogle Scholar
  9. Brandt, R., Ali, Z., Sabel, A., McHugh T., & Gilman, P. (2008). Cancer genetics evaluation: Barriers to and improvements for referral. Genetic Testing, 12(1), 9–12.Google Scholar
  10. Brierley, K. L., Campfield, D., Ducane, W., Dohany, L., Donenberg, T., Shannon, K., et al. (2010). Errors in delivery of cancer genetics services: Implications for practice. Connecticut Medicine, 74(7), 413–423.PubMedGoogle Scholar
  11. Collins, V., Halliday, J., Warren, R., & Williamson, R. (2000). Assessment of education and counselling offered by a familial colorectal cancer clinic. Clinical Genetics, 57(1), 48–55.PubMedCrossRefGoogle Scholar
  12. Ellis, C. N. (2008). Inherited colorectal cancer syndromes. retrieved April 18 2011, from American Society of Colon & Rectal Surgeons Web Site: http://www.fascrs.org/physicians/education/core_subjects/2008/inherited_colorectal_cancer_syndromes/
  13. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. (2009). Recommendations from the EGAPP working group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortiality from Lynch syndrome in relatives. Genetics in Medicine, 11(1), 35–41.CrossRefGoogle Scholar
  14. Freedman, A. N., Wideroff, L., Olson, L., Davis, W., Klabunde, C., Srinath, K. P., et al. (2003). US physicians’ attitudes toward genetic testing for cancer susceptibility. American Journal of Medical Genetics, 120A, 63–71.PubMedCrossRefGoogle Scholar
  15. Grover, S., Stoffel, E. M., Bussone, L., Tschoegl, E., & Syngal, S. (2004). Physician assessment of family cancer history and referral for genetic evalution in colorectal cancer patients. Clinical Gastroenterology and Hepatology, 2, 813–819.PubMedCrossRefGoogle Scholar
  16. Hendricks, Y. M. C., de Jong, A. E., Morreau, H., Tops, C., Vasen, H. F. A., Wijnen, J. T., et al. (2006). Diagnostic approach and management of Lynch syndrome (Hereditary Nonpolyposis Colorectal Carcinoma): A guide for clinicians. CA: A Cancer Journal for Clinicians, 56(4), 213–225.CrossRefGoogle Scholar
  17. Huizenga, C. R., Lowstuter, K., Banks, K. C., Lagos, V. I., Vandergon, V. O., & Weitzel, J. N. (2010). Evolving perspectives on genetic discrimination in health insurance among health care providers. Familial Cancer, 9, 253–260.PubMedCrossRefGoogle Scholar
  18. Järvinen, H. J., Aarnio, M., Mustonen, H., Aktan-Collan, K., Aaltonen, L. A., Peltomäki, P., et al. (2000). Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology, 118, 829–834.PubMedCrossRefGoogle Scholar
  19. Jenab-Wolcott, J., Tan, K., Heitjan, D. F., Giantonio, B. J., Garin, M., Powers, J., et al. (2011). Evaluation of physician knowledge and referral practices for colorectal cancer (CRC) genetic risk assessment: The experience at the Hospital of University of Pennsylvania (HUP) [Abstract]. Journal of Clinical Oncology, 29(suppl 4; abstr 379)Google Scholar
  20. Koil, C. E., Everett, J. N., Hoechstetter, L., Ricer, R. E., & Huelsman, K. M. (2003). Differences in physician referral practices and attitudes regarding hereditary breast cancer by clinical practice location. Genetics in Medicine, 5(5), 364–369.PubMedCrossRefGoogle Scholar
  21. Lowstuter, K. J., Sand, S., Blazer, K. R., MacDonald, D. J., Banks, K. C., Lee, C. A., et al. (2008). Influence of genetic discrimination perceptions and knowledge on cancer genetics referral practice among clinicians. Genetics in Medicine, 10(9), 691–698.PubMedCrossRefGoogle Scholar
  22. McCann, S., MacAuley, D., Barnett, Y., Bunting, B., Bradley, A., Jeffers, L., et al. (2007). Cancer genetics: Consultants’ perceptions of their roles, confidence and satisfaction with knowledge. Journal of Evaluation in Clinical Practice, 13, 276–286.PubMedCrossRefGoogle Scholar
  23. Mukherjee, A., McGarrity, T. J., Ruggerio, F., Koltun, W., McKenna, K., Portiz, L., et al. (2010). The revised Bethesda guidelines: Extent of utilization in a university hospital medical center with a cancer genetics program. Hereditary Cancer in Clinical Practice, 8(9).Google Scholar
  24. National Comprehensive Cancer Network (NCCN). (2011). NCCN clinical practice guidelines in onocology: Genetic/familial high-risk assessment: Breast and ovarian Google Scholar
  25. National Society of Genetic Counselors (NSGC). (2011). JEMF award recipients. Retrieved April 19, 2011, from http://www.nsgc.org/MemberCenter/GrantsAwards/JEMFAwardRecipients/tabid/256/Default.aspx
  26. Peters, J. A., & Biesecker, B. (1997). Genetic counseling and hereditary cancer. Cancer, 80(3), 577–586.CrossRefGoogle Scholar
  27. Singh, H., Schiesser, R., Anand, G., Richardson, P. A., & El-Serag, H. B. (2010). Underdiagnosis of Lynch syndrome involves more than family history criteria. Clinical Gastroenterology and Hepatology, 8, 523–529.PubMedCrossRefGoogle Scholar
  28. Terdiman, J. P. (2005). Colorectal cancer at a young age. Gastroenterology, 128, 1067–1076.PubMedCrossRefGoogle Scholar
  29. U.S. Preventive Services Task Force. (2005). Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Recommendation statement. Annals of Internal Medicine, 143(5), 335–361.Google Scholar
  30. Wideroff, L., Freedman, A. N., Olson, L., Klabunde, C., Davis, W., Srinath, K. P., et al. (2003). Physician use of genetic testing for cancer susceptibility: Results of a national survey. Cancer Epidemiology, Biomarkers & Prevention, 12, 295–303.Google Scholar
  31. Wong, C., Gibbs, P., Johns, J., Jones, I., Faragher, I., Lynch, E., et al. (2008). Value of database linkage: Are patients at risk of familial colorectal cancer being referred for genetic counseling and testing? Internal Medicine Journal, 38, 328–333.PubMedCrossRefGoogle Scholar

Copyright information

© National Society of Genetic Counselors, Inc. 2011

Authors and Affiliations

  • Carrie F. Prochniak
    • 1
  • Lisa J. Martin
    • 2
  • Erin M. Miller
    • 3
  • Sara C. Knapke
    • 4
  1. 1.Department of Women’s Health/OncologyAurora Health CareMilwaukeeUSA
  2. 2.Divisions of Biostatistics and Epidemiology and Human Genetics, Department of Pediatrics, Cincinnati Children’s Hospital Medical CenterUniversity of Cincinnati School of MedicineCincinnatiUSA
  3. 3.The Heart Institute, Cincinnati Children’s Hospital Medical CenterCincinnatiUSA
  4. 4.Division of Human Genetics, Cincinnati Children’s Hospital Medical CenterCincinnatiUSA

Personalised recommendations